Recognizing Opioid Addiction as a Health Epidemic

On June 22, Katie McCloskey, UCF Director of Social Responsibility, delivered a speech at the 2019 General Synod to introduce the Opioid Epidemic resolution. After her address, the resolution passed overwhelmingly.

UCF Work in Support of Resolution to Address Opioid Epidemic

United Church Funds is proud of its work to mitigate the opioid epidemic and produced the following report to inform General Synod 2019 delegates about its accomplishments in relation to the resolution of witness, which will be considered at General Synod.

UCF Work in Support of a Resolution to Abolish the Growth and Existence of Private Prisons

United Church Funds has prepared the following report to inform General Synod 2019 delegates about UCF’s position on private prisons and the work for justice on the finance and support of private prison corporations.

UCF Report: Urging Divestment from Fossil Fuels Companies to Address Climate Change

United Church Funds continues its work to address fossil fuels investments and providing our stakeholders with options for investing without fossil fuels exposure.

UCF Leads a Resolution that Generates 79.7% Support from Shareholders

UCF is celebrating the very successful campaign at pharmaceutical company Mallinckrodt, where a resolution that UCF sponsored on lobbying disclosures generated 79.7% support from the company’s shareholders.

How ESG Investing Helps Address the Opioid Crisis

Scially Responsible Investing (SRI) refers to investment strategies that seek not only to provide financial return but also the process…

Advancing Women through Investment

Faith-based investors can support women’s socio-economic advancement through their investment portfolio. This article outlines a brief guideline to help get you started.

UN Declaration of Human Rights Turns 70

UCF joins other members of the Investor Alliance for Human Rights (IAHR) in celebrating the 70th anniversary of the UN Declaration on Human Rights. We are proud to be a member of the IAHR which interprets human rights to be one aspect of investors’ responsibility when making investment decisions.
SRI

21% of Abbvie Shareholders Favor Report on How Drug Pricing Risks are Integrated Into Exec Incentive Programs

At today’s annual shareholder meeting for Abbvie a first-time shareholder proposal questioning the links between executive compensation packages and drug price increases received a solid show of support from investors, signaling to the board of directors that this issue is key to investor confidence about the long-term sustainability of the company.